{
  "paper_metadata": {
    "pmid": "36369333",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the TTR gene variant Val30Met, including penetrance data and patient demographics."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.148G>A",
      "protein_notation": "p.Val50Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 12,
        "demographics": "Mean age 48.3 \u00b1 5.6 years, 5 males and 7 females",
        "phenotype": "Hereditary transthyretin amyloidosis with secondary glaucoma"
      },
      "penetrance_data": {
        "total_carriers_observed": 12,
        "affected_count": 10,
        "unaffected_count": 2,
        "uncertain_count": null,
        "penetrance_percentage": 83.33,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 48,
          "age_at_onset": 32,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Secondary glaucoma associated with ATTRv amyloidosis",
          "evidence_sentence": "This study included 18 eyes of 12 patients with secondary glaucoma associated with ATTRv amyloidosis with an Val30Met mutation."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 48,
          "age_at_onset": 32,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Secondary glaucoma associated with ATTRv amyloidosis",
          "evidence_sentence": "This study included 18 eyes of 12 patients with secondary glaucoma associated with ATTRv amyloidosis with an Val30Met mutation."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": 48,
          "age_at_onset": 32,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Secondary glaucoma associated with ATTRv amyloidosis",
          "evidence_sentence": "This study included 18 eyes of 12 patients with secondary glaucoma associated with ATTRv amyloidosis with an Val30Met mutation."
        },
        {
          "individual_id": "P4",
          "age_at_evaluation": 48,
          "age_at_onset": 32,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Secondary glaucoma associated with ATTRv amyloidosis",
          "evidence_sentence": "This study included 18 eyes of 12 patients with secondary glaucoma associated with ATTRv amyloidosis with an Val30Met mutation."
        },
        {
          "individual_id": "P5",
          "age_at_evaluation": 48,
          "age_at_onset": 32,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Secondary glaucoma associated with ATTRv amyloidosis",
          "evidence_sentence": "This study included 18 eyes of 12 patients with secondary glaucoma associated with ATTRv amyloidosis with an Val30Met mutation."
        },
        {
          "individual_id": "P6",
          "age_at_evaluation": 48,
          "age_at_onset": 32,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Secondary glaucoma associated with ATTRv amyloidosis",
          "evidence_sentence": "This study included 18 eyes of 12 patients with secondary glaucoma associated with ATTRv amyloidosis with an Val30Met mutation."
        },
        {
          "individual_id": "P7",
          "age_at_evaluation": 48,
          "age_at_onset": 32,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Secondary glaucoma associated with ATTRv amyloidosis",
          "evidence_sentence": "This study included 18 eyes of 12 patients with secondary glaucoma associated with ATTRv amyloidosis with an Val30Met mutation."
        },
        {
          "individual_id": "P8",
          "age_at_evaluation": 48,
          "age_at_onset": 32,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "No symptoms of glaucoma",
          "evidence_sentence": "This study included 18 eyes of 12 patients with secondary glaucoma associated with ATTRv amyloidosis with an Val30Met mutation."
        },
        {
          "individual_id": "P9",
          "age_at_evaluation": 48,
          "age_at_onset": 32,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "No symptoms of glaucoma",
          "evidence_sentence": "This study included 18 eyes of 12 patients with secondary glaucoma associated with ATTRv amyloidosis with an Val30Met mutation."
        }
      ],
      "functional_data": {
        "summary": "The Val30Met mutation in TTR is known to cause amyloid deposition leading to systemic and ocular complications.",
        "assays": []
      },
      "segregation_data": "The Val30Met variant is known to segregate with disease in families affected by ATTRv amyloidosis.",
      "population_frequency": null,
      "evidence_level": "high",
      "source_location": "Results, paragraph 1",
      "additional_notes": "The study highlights the impact of the Val30Met mutation on secondary glaucoma.",
      "key_quotes": [
        "All patients underwent liver transplantation at the mean age of 33.5 \u00b1 5.9 years.",
        "Ten eyes (56%) of eight patients were classified as surgical failures."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "Data was extracted thoroughly from the main text."
  }
}